Summary: Low bioavailability can lead to development challenges. Advanced formulation expertise and technologies can increase the chance of success in the clinic.
Summary: A fast, efficient development process can deliver the right clinical candidate, best formulation strategy, and optimal dosage form to Phase 1.
Summary: Learn the strategies to avoid costly pitfalls in pharmaceutical consulting and Gain inside tips on using CDMO’s to deliver solutions to your clients.
Summary: This 90-minute virtual workshop includes presentations from BASF and Catalent that demonstrate on how lipid-based drug softgel technology can provide formulators with an effective delivery…
Summary: This webinar focuses on the key considerations for transitioning small molecules from preclinical through clinical development.
